Song, Y.-Q., Zhang, H.-L., Huang, H.-Q., Zhang, Q.-Y., Jing, H.-M., Wang, C., Wu, C., Li, D.-H., Dai, Y., Humphrey, K. and Zhu, J. (2024) “Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma”, Haematologica. Pavia, Italy, 109(4), pp. 1269-1273. doi: 10.3324/haematol.2023.283802.